NMR, and MS). The new compounds were screened as cyclooxygenase-1/ cyclooxygenase-2 (COX-1/COX-2) inhibitors and had analgesic and anti-inflammatory activities. The compounds 10a–d and 13a–f had the highest inhibitory activity on COX-2 selectivity, with indices of 99–90, analgesic activity of 51–42% protection, and anti-inflammatory activity of 68%–59%. The inhibition of edema for the same compounds
新型 (4-甲氧基或 4,8-二甲氧基)-3-甲基-N-(6-oxo-2-thioxo-1,2,3, 6-tetrahydro-pyrimidin-4-yl) 苯并 [1,2- b: 5, 4-b'] difuran-2-carboxamide (5a-b) 是通过 visnagenone-
乙酸乙酯 (2a) 或 khellinone-
乙酸乙酯 (2b) 与 6-
氨基
硫尿
嘧啶在二甲基甲酰胺中的反应或
苯并呋喃的回流合成的。 oxy-N-(2-thioxopyrimidine) 乙酰胺 (4a-b) 的
乙醇钠溶液以良好的收率得到相同的产物 (5a,b)。因此,化合物 5a-b 被用作制备许多新的
杂环化合物,如 2-(4-(3-methylbenzodifuran-2-carbox-amido) pyrimidine)
乙酸 (6a-b)、N-(thiazolo[ 3, 2-a]
嘧啶)-3-甲基苯并二
呋喃-2-甲酰胺